The constellation of metabolic abnormalities including centrally distributed obesity,
decreased high‐density lipoprotein cholesterol (HDL‐C), elevated triglycerides, elevated …

Introduction: Metabolic syndrome (MetS) defines the clustering in an individual of multiple
metabolic abnormalities, based on central obesity and insulin resistance. In addition to its …

An increased risk of coronary heart disease (CHD) morbidity and mortality is associated with
the metabolic syndrome, a condition characterized by the concomitant presence of several …

Increase in prevalence of obesity has become a worldwide major health problem in adults,
as well as among children and adolescents. Furthermore, total adiposity and truncal …

The term metabolic syndrome refers to a virulent and lethal group of atherosclerotic risk
factors, including dyslipidemia, insulin resistance, obesity, and hypertension. This syndrome …

The metabolic syndrome (MS) is a clustering of cardiovascular risk factors, with insulin
resistance as a major feature. This syndrome has been variously defined, but generally …

Atherosclerosis is a leading cause of morbidity and mortality in populations around the
world. The clustering of risk factors for atherosclerosis, such as abnormal glucose tolerance …

There are a number of official definitions of Metabolic Syndrome; still there is an ongoing
international debate on its existence. Metabolic syndrome is the result of highly complex …

Despite criticism regarding its clinical relevance, the concept of the metabolic syndrome
improves our understanding of both the pathophysiology of insulin resistance and its …

Metabolic syndrome (MetS) is a widely prevalent and multi-factorial disorder. The syndrome
has been given several names such as insulin resistance (IR) syndrome, plurimetabolic …